Background Delirium is the most common cerebral dysfunction in the intensive care unit (ICU)
and can be subdivided into a hypoactive, hyperactive, or mixed motor subtype based on …

Importance Supplemental oxygen is ubiquitously used in patients with COVID-19 and severe
hypoxemia, but a lower dose may be beneficial. Objective To assess the effects of targeting …

Background Characteristics and care of intensive care unit (ICU) patients with COVID‐19
may have changed during the pandemic, but longitudinal data assessing this are limited. We …

Background ICU admission due to COVID‐19 may result in cognitive and physical impairment.
We investigated the long‐term cognitive and physical status of Danish ICU patients with …

Background Intensive care unit (ICU) patients with Coronavirus disease 2019 (COVID‐19)
have an increased risk of thromboembolic complications. We describe the occurrence of …

Background Thromboembolism is more common in patients with critical COVID-19 than in
other critically ill patients, and inflammation has been proposed as a possible mechanism. …

IMPORTANCE Dexamethasone 6 mg daily is recommended for up to 10 days in patients
with severe and critical COVID-19, but a higher dose may benefit those with more severe …

Background In the COVID-STEROID 2 trial there was suggestion of heterogeneity of treatment
effects (HTE) between patients enrolled from Europe vs. India on the primary outcome. …

Background: Delirium is the most common cerebral dysfunction in the intensive care unit (ICU)
and can be sub‑divided into a hypoactive, hyperactive, or mixed motor subtype based on …

Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support
in Adults With COVID-19 and Severe Hypoxemia: The COVID STEROID 2 Randomized Trial …